ChemomAb Therapeutics Ltd. Analysis
| Analyst Ratings |
|
Average Target Price
|
16.33
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
3
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-12-31
|
-0.68
|
0.00
|
0.68
|
100.00%
|
|
2022-09-30
|
-0.33
|
-0.04
|
0.29
|
87.88%
|
|
2022-06-30
|
-0.25
|
-0.54
|
-0.29
|
-116.00%
|
|
2022-03-31
|
-0.24
|
-0.44
|
-0.20
|
-83.33%
|
|
2021-12-31
|
-0.10
|
-0.44
|
-0.34
|
-340.00%
|
|
2021-09-30
|
-0.14
|
-0.26
|
-0.12
|
-85.71%
|
|
2021-06-30
|
-0.11
|
-0.26
|
-0.15
|
-136.36%
|
|
2021-03-31
|
-0.43
|
-0.22
|
0.21
|
48.84%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.02
|
|
2021-12-31
|
-1.18
|
|
2020-12-31
|
-8.24
|
|
2019-12-31
|
-63.20
|
|
2018-12-31
|
-0.12
|